CUSIP 00653A107SPONDS ADSADAPYQ4 2025
31 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Josh Arnold Investment Consultant, LLC | 20.0K | $37.8K |
| 2 | Empirical Finance, LLC | 800.0K | $20.8K |
| 3 | Rathbones Group PLC | 432.8K | $11.3K |
| 4 | Xtx Topco Ltd | 353.8K | $9.2K |
| 5 | Simplex Trading, LLC | 18.6K | $483 |
| 6 | Rhumbline Advisers | 3.7K | $95 |
| 7 | Barclays PLC | 2.5K | $66 |
| 8 | X-Square Capital, LLC | 11.4K | $0 |
| 9 | Acadian Asset Management LLC |
| 4 | Aug 19, 2025 | Ecor1 Capital, LLC | 13G/A | 4.2% | — | SEC |
| 5 | Aug 13, 2025 | Two Seas Capital LP | 13G/A | 8.5% | — | SEC |
| 6 | May 15, 2025 | Two Seas Capital LP | 13G/A | 8.0% | — | SEC |
| 7 | Feb 14, 2025 | Two Seas Capital LP | 13G | 5.8% | — | SEC |
| 8 | Feb 12, 2025 | Baillie Gifford &Amp; Co | 13G/A | 4.6% | 7091.46T | SEC |
| 9 | Feb 11, 2025 | Long Focus Capital Management, LLC | 13G/A | 8.0% | 20.49M | SEC |
| 10 | Jan 8, 2025 | Matrix Capital Management Company LP | 13G/A | — | 49 | SEC |
See the full Schedule 13D/13G history for Adaptimmune Therapeutics PLC.
Unlock full history| 17.2K |
| $0 |
| 10 | Td Waterhouse Canada Inc. | 14 | $0 |